Literature DB >> 34837014

Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.

Shannon L Kordus1,2, Audrey K Thomas1,2, D Borden Lacy3,4,5.   

Abstract

Clostridioides difficile is a Gram-positive anaerobe that can cause a spectrum of disorders that range in severity from mild diarrhoea to fulminant colitis and/or death. The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea. In this Review, we highlight recent biochemical and structural advances in our understanding of the mechanisms that govern host-toxin interactions. Understanding how C. difficile toxins affect the host forms a foundation for developing novel strategies for treatment and prevention of C. difficile infection.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34837014      PMCID: PMC9018519          DOI: 10.1038/s41579-021-00660-2

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   78.297


  170 in total

1.  Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.

Authors:  E Chaves-Olarte; M Weidmann; C Eichel-Streiber; M Thelestam
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  The chaperonin TRiC/CCT is essential for the action of bacterial glycosylating protein toxins like Clostridium difficile toxins A and B.

Authors:  Marcus Steinemann; Andreas Schlosser; Thomas Jank; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

3.  Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.

Authors:  M R Popoff; E J Rubin; D M Gill; P Boquet
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

4.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

5.  Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

Authors:  Glen P Carter; Anjana Chakravorty; Tu Anh Pham Nguyen; Steven Mileto; Fernanda Schreiber; Lucy Li; Pauline Howarth; Simon Clare; Bliss Cunningham; Susan P Sambol; Adam Cheknis; Iris Figueroa; Stuart Johnson; Dale Gerding; Julian I Rood; Gordon Dougan; Trevor D Lawley; Dena Lyras
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

6.  The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5.

Authors:  Briony Elliott; Kate E Dingle; Xavier Didelot; Derrick W Crook; Thomas V Riley
Journal:  Genome Biol Evol       Date:  2014-11-08       Impact factor: 3.416

7.  The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding.

Authors:  Soo-Young Chung; Dennis Schöttelndreier; Helma Tatge; Viola Fühner; Michael Hust; Lara-Antonia Beer; Ralf Gerhard
Journal:  Front Microbiol       Date:  2018-10-26       Impact factor: 5.640

Review 8.  The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Current Understanding and Gap Analysis.

Authors:  Mark H Wilcox; Barbara H McGovern; Gail A Hecht
Journal:  Open Forum Infect Dis       Date:  2020-04-11       Impact factor: 3.835

Review 9.  Large Clostridial Toxins: Mechanisms and Roles in Disease.

Authors:  Kathleen E Orrell; Roman A Melnyk
Journal:  Microbiol Mol Biol Rev       Date:  2021-06-02       Impact factor: 13.044

10.  The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI.

Authors:  Megan Garland; Andrew J Hryckowian; Martina Tholen; Kristina Oresic Bender; William W Van Treuren; Sebastian Loscher; Justin L Sonnenburg; Matthew Bogyo
Journal:  Cell Rep Med       Date:  2020-04-21
View more
  13 in total

Review 1.  From signal transduction to protein toxins-a narrative review about milestones on the research route of C. difficile toxins.

Authors:  Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-07       Impact factor: 3.195

2.  Human α-Defensin-6 Neutralizes Clostridioides difficile Toxins TcdA and TcdB by Direct Binding.

Authors:  Lara Barthold; Sebastian Heber; Christoph Q Schmidt; Marion Gradl; Gilbert Weidinger; Holger Barth; Stephan Fischer
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes.

Authors:  Rosemary L Pope; Alisha Chitrakar; Prakash Sah; Tyler Shadid; Jimmy D Ballard; Lauren A Zenewicz
Journal:  Infect Immun       Date:  2022-04-04       Impact factor: 3.609

4.  Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.

Authors:  Baohua Chen; Zheng Liu; Kay Perry; Rongsheng Jin
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

Review 5.  An Update on Clostridioides difficile Binary Toxin.

Authors:  Adrián Martínez-Meléndez; Flora Cruz-López; Rayo Morfin-Otero; Héctor J Maldonado-Garza; Elvira Garza-González
Journal:  Toxins (Basel)       Date:  2022-04-27       Impact factor: 5.075

6.  Novel C. difficile toxin receptor.

Authors:  Ursula Hofer
Journal:  Nat Rev Microbiol       Date:  2022-06       Impact factor: 60.633

7.  Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.

Authors:  F Christopher Peritore-Galve; John A Shupe; Rory J Cave; Kevin O Childress; M Kay Washington; Sarah A Kuehne; D Borden Lacy
Journal:  PLoS Pathog       Date:  2022-02-17       Impact factor: 6.823

8.  TcdB of Clostridioides difficile Mediates RAS-Dependent Necrosis in Epithelial Cells.

Authors:  Florian Stieglitz; Ralf Gerhard; Rabea Hönig; Klaudia Giehl; Andreas Pich
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

9.  Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol.

Authors:  Sebastian Heber; Lara Barthold; Jan Baier; Panagiotis Papatheodorou; Giorgio Fois; Manfred Frick; Holger Barth; Stephan Fischer
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

10.  The Essential Role of Rac1 Glucosylation in Clostridioides difficile Toxin B-Induced Arrest of G1-S Transition.

Authors:  Lara Petersen; Svenja Stroh; Dennis Schöttelndreier; Guntram A Grassl; Klemens Rottner; Cord Brakebusch; Jörg Fahrer; Harald Genth
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.